Zobrazeno 1 - 10
of 45
pro vyhledávání: '"V, Laini"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sergio Manfré, V. Laini, Massimo C. Mauri, G. Panza, Francesca Regispani, Marta E. Scalvini, L. Boscati, Lara Malvini, L.S. Volonteri, Giancarlo Cerveri
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26:597-601
Sertraline (SRT) has been shown to be an effective antidepressant in extensive clinical trial programs but data on plasma concentrations regarding clinical outcome and tolerability are lacking. Twenty-one out-patients of both sexes, with mean age of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::860d7cefb9dfd5de86a5cc6f3cb65dcd
https://doi.org/10.1016/s0278-5846(01)00314-1
https://doi.org/10.1016/s0278-5846(01)00314-1
Autor:
Veronica Ferrari, Massimo Carlo Mauri, Giovanni Maria Ruggiero, Mario Mantero, Gabriella Redaelli, V. Laini, Franco Lugo, Alessandra Clemente, Francesco Cavagnini, Daniela Zappulli
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25:1049-1059
1. The study evaluated the efficacy of amisulpride, fluoxetine and clomipramine at the beginning of the re-feeding phase of the treatment of restricting anorexia nervosa according to DSM-IV criteria. 2. 13 patients, mean weight 37.61 kg +/- 9.80 SD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c1eb367e9b875149b5101ef8b39d0c
https://doi.org/10.1016/s0278-5846(01)00174-9
https://doi.org/10.1016/s0278-5846(01)00174-9
Publikováno v:
European psychiatry (Ed. Española). 8:155-162
ResumenSe trató a 24 pacientes ambulatorios esquizofrénicos crónicos con una edad media de 37,21 años ± 9,96 DT con risperidona (RSP) en una dosis de 2-9 mg/día (media = 4,46 mg/día ± 1,30 DT, media = 0,06 mg/kg ± 0,01 DT) durante un año.La
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dcfe32a67db38db03a2fb8766c36db1
https://doi.org/10.1017/s1134066500006226
https://doi.org/10.1017/s1134066500006226
Autor:
Veronica Ferrari, Marta E. Scalvini, Anna Caterina Omboni, Giancarlo Cerveri, Virginio Salvi, Massimo C. Mauri, Alessandra Clemente, V. Laini
Publikováno v:
Scopus-Elsevier
Gabapentin (GBP) is a new anticonvulsant drug that has shown efficacy in the treatment of epilepsy, several neurological disorders (pain syndromes, acquired nystagmus, Huntington’s chorea, amyotrophic lateral sclerosis), and more recently in the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0b847218dc78be759091370a1ab307
https://doi.org/10.2165/00044011-200121030-00002
https://doi.org/10.2165/00044011-200121030-00002
Autor:
C. P C Steinhilber, L.S. Volonteri, V. Laini, Massimo C. Mauri, Marta E. Scalvini, Federica Zamberlan, L. Boscati
Publikováno v:
Neuropsychobiology. 44:134-138
Sixteen outpatients (mean age ± SD 50.18 ± 11.55 years; 11 females and 5 males) affected by major depression without melancholia (DSM-IV) were included in the study. The control group consisted of 11 healthy volunteers (mean age ± SD 39.90 ± 13.3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968328a82bdfe137decd1a1e4274a617
https://doi.org/10.1159/000054933
https://doi.org/10.1159/000054933
Autor:
Lorenzo Mapelli, Antonella Bitetto, Renata Rudelli, Massimo C. Mauri, L. Boscati, Marta E. Scalvini, V. Laini
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 3:115-119
Depressive disorders can be regarded as recurrent and chronic conditions that may reduce the quality of life and work output of patients. Data on the long-term efficacy of paroxetine appear to indicate that it is an effective maintenance treatment. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074418ebdf2624ba3642214cb35d698b
https://doi.org/10.3109/13651509909024771
https://doi.org/10.3109/13651509909024771
Autor:
M C, Mauri, V, Laini, R, Barone, A, Clemente, L S, Volonteri, G, Cerveri, C, Steinhilber, M, Fornier
Publikováno v:
L'Encephale. 26(6)
Forty three patients, mean age 55.20 +/- 9.27 SD, affected by Schizophrenia Residual Type (DSM IV, RDC criteria) and treated with neuroleptic drugs for a mean of 25.42 years (+/- 4.12 SD) were included into the study. Clinical evaluation was cross-se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e4993f8b244288b614eb034e077e1e6
https://pubmed.ncbi.nlm.nih.gov/11217534
https://pubmed.ncbi.nlm.nih.gov/11217534
Publikováno v:
European review for medical and pharmacological sciences. 3(2)
From many decades efficacy of lithium salts, as mood stabilizers, has been largely recognized, but their tolerability, in particular during intermediate or long-term treatments is still discussed. The most frequently described side effects can affect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::54c99e824ed533492dee9bbb6f85fa75
https://pubmed.ncbi.nlm.nih.gov/10827806
https://pubmed.ncbi.nlm.nih.gov/10827806
Autor:
V. Laini, Farouk Rafique, C. P C Steinhilber, Monica Fornier, Massimo C. Mauri, Antonella Bitetto, Lorenza Fabiano
Publikováno v:
Progress in neuro-psychopharmacologybiological psychiatry. 23(1)
1. 1. A prevalence of depressive symptomatology, ranging from 25% to 80% has been reported during the course of schizophrenia. 2. 2. Depressive symptoms were assessed in 144 schizophrenic patients (DSM IV) during an acute exacerbation phase. 3. 3. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6809f605f99c94a840a074b683b627d
https://pubmed.ncbi.nlm.nih.gov/10368855
https://pubmed.ncbi.nlm.nih.gov/10368855